Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126425431 | 12642543 | 1 | I | 201607 | 20160804 | 20160810 | 20160810 | EXP | US-BAUSCH-BL-2016-018894 | BAUSCH AND LOMB | 61.11 | YR | M | Y | 86.71000 | KG | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126425431 | 12642543 | 1 | PS | XIFAXAN | RIFAXIMIN | 1 | Oral | SMPT | 21361 | 550 | MG | TABLET | BID | ||||||
| 126425431 | 12642543 | 2 | SS | LACTULOSE. | LACTULOSE | 1 | Oral | 0 | 30 | ML | TID | ||||||||
| 126425431 | 12642543 | 3 | SS | LACTULOSE. | LACTULOSE | 1 | Oral | 4-5 TIMES DAILY | 0 | 30 | ML | ||||||||
| 126425431 | 12642543 | 4 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 0 | |||||||||||
| 126425431 | 12642543 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | |||||||||||
| 126425431 | 12642543 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | 50000 | IU | /wk | ||||||||
| 126425431 | 12642543 | 7 | C | ZINC SULFATE | ZINC SULFATEINC SULFATE ANHYDROUS | 1 | Oral | 0 | |||||||||||
| 126425431 | 12642543 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | |||||||||||
| 126425431 | 12642543 | 9 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 0 | |||||||||||
| 126425431 | 12642543 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | |||||||||||
| 126425431 | 12642543 | 11 | C | TACROLIMUS. | TACROLIMUS | 1 | Oral | 0 | |||||||||||
| 126425431 | 12642543 | 12 | C | APIDRA | INSULIN GLULISINE | 1 | 0 | ||||||||||||
| 126425431 | 12642543 | 13 | C | TOUJEO | INSULIN GLARGINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126425431 | 12642543 | 1 | Hepatic encephalopathy |
| 126425431 | 12642543 | 2 | Hepatic encephalopathy |
| 126425431 | 12642543 | 4 | Hypertension |
| 126425431 | 12642543 | 5 | Hypertension |
| 126425431 | 12642543 | 6 | Vitamin D deficiency |
| 126425431 | 12642543 | 7 | Supplementation therapy |
| 126425431 | 12642543 | 8 | Product used for unknown indication |
| 126425431 | 12642543 | 9 | Supplementation therapy |
| 126425431 | 12642543 | 10 | Hypertension |
| 126425431 | 12642543 | 11 | Liver transplant |
| 126425431 | 12642543 | 12 | Diabetes mellitus |
| 126425431 | 12642543 | 13 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126425431 | 12642543 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126425431 | 12642543 | Ammonia increased | |
| 126425431 | 12642543 | Loss of consciousness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |